CFDs are a leveraged product and can result in losses that exceed deposits. Please ensure you fully understand how CFDs work and what their risks are, and take care to manage your exposure. CFDs are a leveraged product and can result in losses that exceed deposits. Please ensure you fully understand how CFDs work and what their risks are, and take care to manage your exposure.

Pfizer share price: what to expect from Q1 result

In this article we find out what we can expect from the upcoming Pfizer results, how they could affect the Pfizer share price as well as how to trade the  earnings.

When is Pfizer earnings date?

The Pfizer earnings release date is scheduled for the 4 May. The results will cover the groups quarter one (Q1) financial year 2021 (FY21) earnings (January to March 2021).

Pfizer results preview: what does the Street expect?

Pfizer, the research based global biopharmaceutical company, is expected to see low double digit revenue growth for Q1 2021 when compared to the prior year’s comparative period (Q1 2020), although earnings per share for the period are expected to be relatively flat against the comparative due to an increased cost base.

The average estimates for the upcoming results are as follows:

How to trade Pfizer Q1 results

The two graphics below provide traders with both a retail short-term view on the stock, as well as an institutional longer-term view on the Pfizer share price, as to how market participants are positioned ahead of the Q1 earnings release.

A Refinitiv poll of 22 analysts maintain a long-term average rating of ‘hold’ for Pfizer (as of 3 May), with two of these analysts recommending a strong buy, five recommending a buy, 15 hold, zero sell and zero strong sell recommendations on the stock.

From a retail trader perspective (as of 3 May), 99% of IG clients with open positions on the Pfizer expect the share price to rise over the near term, while 1% of IG clients with open positions expect the Pfizer price to fall.

Pfizer share price: technical analysis

The Pfizer share price is currently testing resistance of the $33.40 to $39.30 range within which it currently trades.

For a bullish trading scenario, traders will want to see a confirmed (with a daily close) break of the $39.30 level, before targeting a move to the near term high at $42.90. In this scenario, a close below the dotted trend line may be used as a stop loss consideration.

For a bearish trading scenario, a close below the dotted trend line support could indicate that the price is now looking to return to range support at $33.40. In this scenario, $33.40 becomes the downside target, while a close above range resistance at $39.30 could be used as a stop loss consideration for the trade.

In summary

  • Pfizer Q1 FY21 results are scheduled for release on the 4 May
  • Group revenue for the quarter is expected to be realized at $13.6 billion
  • EPS for the quarter is expected to be realized at $0.78
  • The majority of IG clients with open positions on Pfizer expect the price to rise in the near term
  • A technical analysis view on the Pfizer share price shows a short to medium-term rangebound price environment

This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.

Act on share opportunities today

Go long or short on thousands of international stocks with CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Try a risk-free trade
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Forex
  • Shares
  • Indices
liveprices.javascriptrequired
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Friday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.